Second drug with breakthrough therapy designation to receive FDA approval Silver Spring, Maryland–(ENEWSPF)–November 13, 2013. The U.S. Food and Drug Administration today approved Imbruvica (ibrutinib) to treat patients with mantle cell lymphoma (MCL), a rare and aggressive type of blood cancer. MCL is a rare form of non-Hodgkin lymphoma and[Read More…]
Health and Fitness
Medical Marijuana Advocates Hold Press Conference Ahead of Public Hearing on Fate of Washington State Program
Stakeholders speak out to defend state’s 15-year-old law and urge legislators to preserve, strengthen patients’ rights Seattle, WA—(ENEWSPF)—November 13, 2013. Patient advocates and various stakeholders will hold a press conference today at 4pm at Saint Martin’s University in Lacey to draw attention to this evening’s statewide public hearing on the[Read More…]
New Prevention Guidelines Address Blood Cholesterol, Obesity, Healthy Living and Risk Assessment
Washington, DC–(ENEWSPF)–November 12, 2013. The American College of Cardiology (ACC) and the American Heart Association (AHA), in collaboration with the National Heart, Lung, and Blood Institute (NHLBI) and other specialty societies, have released four guidelines focused on the assessment of cardiovascular risk, lifestyle modifications to reduce cardiovascular risk and management[Read More…]
Mayor Emanuel Visits GoHealth to Announce a Total of Over 650 New Jobs as a Part of 2014 Health Insurance Enrollment Effort
GoHealth Exceeds Initial 2013 Job Estimate By Hundreds as a Part of Company’s Expansion Into New Space at Merchandise Mart, Adding Formerly Unemployed Workers through Strong Partnership with Skills for Chicagoland’s Future CHICAGO–(ENEWSPF)–November 12, 2013. Mayor Emanuel today joined Brandon Cruz and Clint Jones, co-founders of GoHealth, to announce that[Read More…]
Teen Night Owls Likely to Perform Worse Academically, Emotionally
Teenagers who go to bed late during the school year were found to be struggling academically (iStockphoto) BERKELEY–(ENEWSPF)–November 12, 2013. Teenagers who go to bed late during the school year are more prone to academic and emotional difficulties in the long run, compared to their earlier-to-bed counterparts, according to a[Read More…]
Cell Phone Radiation Varies By Wireless Carrier
Washington, D.C.–(ENEWSPF)–November 12, 2013. In recent years, a series of studies have shown that a consumer’s choice of wireless carrier may be more important than the cell phone itself in determining how much radiation will reach the user, according to a new analysis by researchers at the Environmental Working Group.[Read More…]
What Preschoolers Know About Healthy Eating
ANN ARBOR–(ENEWSPF)–November 12, 2013. When you hand a preschooler a donut, does she know it’s junk food? The answer is yes, says University of Michigan researcher Kristen Harrison. Harrison, professor of communication studies and faculty associate at the U-M Institute for Social Research, studies predictors of early-childhood obesity by investigating[Read More…]
NIH Launches Trial of Investigational Genital Herpes Vaccine
Bethesda, Maryland–(ENEWSPF)–November 8, 2013. Researchers have launched an early-stage clinical trial of an investigational vaccine designed to prevent genital herpes disease. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the Phase I trial, which is being conducted at the NIH[Read More…]
European Union Officially Rejects Australian Privatized Meat Inspection System
Confirms Food & Water Watch’s Previous Information Washington, D.C.–(ENEWSPF)–November 8, 2013. This past week, the European Commission (EC) posted on its website its final report of the May 2012 audit its staff conducted of the Australian meat inspection system for products destined for Europe and concluded that the privatized meat[Read More…]
FDA Approves First Generic Versions of Aciphex Delayed-release Tablets to Treat GERD
Silver Spring, Maryland—(ENEWSPF)—November 8, 2013. The U.S. Food and Drug Administration today approved the first generic versions of Aciphex (rabeprazole sodium) delayed-release tablets, used to treat gastroesophageal reflux disease (GERD) in adults and adolescents (ages 12 and up). GERD, also called acid reflux or acid regurgitation, is a common condition[Read More…]





